Valuation: Qinghai Biotech Pharmaceutical Group Limited

Market Cap 171M 21.8M 19.13M 18.07M 16.46M 30.82M 2.09B 31.04M 216M 83.73M 1.07B 81.85M 80.08M 3.43B P/E 2024
-2.61x
P/E 2025 -7.56x
Enterprise Value 74.85M 9.54M 8.37M 7.91M 7.21M 13.49M 915M 13.59M 94.64M 36.66M 467M 35.83M 35.05M 1.5B EV / Sales 2024
-0.1x
EV / Sales 2025 1.85x
Free-Float
43.07%
Yield 2024 *
-
Yield 2025 -
1 day-2.94%
1 week-10.08%
Current month-17.50%
1 month-11.05%
3 months-28.26%
6 months-71.79%
Current year-52.86%
1 week 1.6
Extreme 1.6
1.84
1 month 1.6
Extreme 1.6
2
Current year 1.36
Extreme 1.36
10.95
1 year 1.36
Extreme 1.36
10.95
3 years 0.65
Extreme 0.65
10.95
5 years 0.65
Extreme 0.65
11.85
10 years 0.65
Extreme 0.65
29.5
Manager TitleAgeSince
Chief Executive Officer 45 26/02/2019
Comptroller/Controller/Auditor 50 01/04/2016
Director TitleAgeSince
Chairman 45 02/12/2016
Director/Board Member 61 11/01/2017
Director/Board Member 62 05/03/2018
Date Insider Type Main position Quantity % Market Cap. Importance
22/07/20 Other

Director

6,000,000 0.1190%
22/07/20 Other

Chief Executive Officer

40,000,000 0.7933%
22/07/20 Other

Director

6,000,000 0.1190%
Change 5-day change 1-year change 3-year change Capi.($)
-2.94%-10.08%-40.00%-5.71% 21.8M
+1.14%+3.07%+12.12%-20.13% 18.75B
+0.50%+3.88%+9.20%+9.50% 17.27B
-0.35%+6.27%-49.18%-44.97% 6.54B
-0.37%-1.80% - - 3.97B
-0.47%-2.60%+34.13%+69.62% 1.84B
0.00%+0.37%-16.62%-3.01% 1.77B
-2.69%+1.78%-46.72%-61.78% 1.11B
-0.06%+1.14%+54.24%+164.19% 953M
-2.99%-3.17%+45.18%+278.64% 541M
Average -0.82%+0.10%+0.26%+42.93% 5.28B
Weighted average by Cap. +0.39%+2.97%+2.49%-2.99%

Financials

2024 2025
Net sales 185M 23.63M 20.74M 19.58M 17.85M 33.41M 2.26B 33.65M 234M 90.77M 1.16B 88.72M 86.8M 3.72B 139M 17.73M 15.56M 14.7M 13.39M 25.07M 1.7B 25.25M 176M 68.12M 868M 66.59M 65.15M 2.79B
Net income -46.36M -5.91M -5.19M -4.9M -4.46M -8.35M -566M -8.41M -58.61M -22.7M -289M -22.19M -21.71M -930M -46.68M -5.95M -5.22M -4.93M -4.49M -8.41M -570M -8.47M -59.02M -22.86M -291M -22.34M -21.86M -936M
Net Debt -139M -17.71M -15.54M -14.68M -13.38M -25.05M -1.7B -25.22M -176M -68.05M -867M -66.51M -65.07M -2.79B -96.14M -12.26M -10.75M -10.16M -9.26M -17.33M -1.17B -17.45M -122M -47.08M -600M -46.02M -45.02M -1.93B
Logo Qinghai Biotech Pharmaceutical Group Limited
Kaisa Health Group Holdings Ltd, formerly Mega Medical Technology Ltd, is an investment holding company principally engaged in the manufacture and sale of dental prosthetics. The Company operates its business through three segments. The Dental Prosthetics Business segment is engaged in the manufacture and sale of dental prosthetics. The Health Care Rehabilitation Business segment provides public health and medical services, including postoperative rehabilitation, sports injury rehabilitation, chronic pain, scoliosis, deformity correction and other rehabilitation services. The Health Care Health Leisure Business segment provides agricultural (cultural) tourism and construction of health care real estate projects.
Employees
1,340
Date Price Change Volume
25/09/26 HK$1.650 -2.94% 16,000
24/09/26 HK$1.700 -7.36% 40,000
23/09/26 HK$1.835 0.00% 106,000
22/09/26 HK$1.835 0.00% 0
21/09/26 HK$1.835 0.00% 4,000